SLC6A3 and vascular parkinsonism: Thus, striatal DAT assessment may help identifying a comorbid nigrostriatal dopaminergic denervation in doubtful cases with vascular parkinsonism, and this can have therapeutic implications selecting patients who are more likely to response to levodopa [126].